Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,405,916
  • Shares Outstanding, K 701,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -614,930 K
  • 60-Month Beta -0.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 118.59
Trade SMMT with:

Options Overview Details

View History
  • Implied Volatility 95.38% ( -10.48%)
  • Historical Volatility 162.95%
  • IV Percentile 24%
  • IV Rank 11.89%
  • IV High 631.33% on 10/26/23
  • IV Low 23.06% on 10/06/23
  • Put/Call Vol Ratio 0.76
  • Today's Volume 19,117
  • Volume Avg (30-Day) 15,209
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 129,191
  • Open Int (30-Day) 65,271

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.29 +117.54%
on 08/19/24
33.89 -27.53%
on 09/16/24
+12.96 (+111.72%)
since 08/16/24
3-Month
6.78 +262.24%
on 07/03/24
33.89 -27.53%
on 09/16/24
+16.62 (+209.32%)
since 06/18/24
52-Week
1.64 +1,397.56%
on 11/09/23
33.89 -27.53%
on 09/16/24
+22.75 (+1,256.91%)
since 09/18/23

Most Recent Stories

More News
This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.

There's a lot of hope for ivonescimab, but are investors being a bit too bullish?

MRK : 118.64 (+0.30%)
SMMT : 24.56 (-6.33%)
Here's Why Everyone's Talking About Summit Therapeutics

Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.

SMMT : 24.56 (-6.33%)
TIL : 66.10 (+2.02%)
BNTX : 115.62 (-7.29%)
Up 1,123% YTD, Is It Too Late to Buy This Breakout Biotech Stock?

Summit Therapeutics is a clinical-stage biotech company that has returned over 1,100% in 2024. Is the stock still a good buy right now?

SMMT : 24.56 (-6.33%)
MRK : 118.64 (+0.30%)
C : 59.90 (+1.03%)
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?

A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.

TIL : 66.10 (+2.02%)
SMMT : 24.56 (-6.33%)
Stocks Rally on Heightened Speculation about a 50 bp Rate Cut Next Week

The S&P 500 Index ($SPX ) (SPY ) Friday closed up by +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.47%. Stocks posted...

$SPX : 5,618.26 (-0.29%)
SPY : 561.40 (-0.30%)
$DOWI : 41,503.10 (-0.25%)
DIA : 416.19 (-0.26%)
$IUXX : 19,344.49 (-0.45%)
QQQ : 471.44 (-0.43%)
ZNZ24 : 114-265 (-0.22%)
MU : 87.35 (-1.56%)
ON : 70.64 (-1.09%)
AMAT : 186.14 (-1.30%)
MCHP : 76.36 (-0.83%)
KLAC : 731.04 (-1.16%)
Stocks Push Higher on Chip Stock Strength and Positive Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.42%. Stocks today are moderately...

$SPX : 5,618.26 (-0.29%)
SPY : 561.40 (-0.30%)
$DOWI : 41,503.10 (-0.25%)
DIA : 416.19 (-0.26%)
$IUXX : 19,344.49 (-0.45%)
QQQ : 471.44 (-0.43%)
ZNZ24 : 114-265 (-0.22%)
MU : 87.35 (-1.56%)
ON : 70.64 (-1.09%)
AMAT : 186.14 (-1.30%)
MCHP : 76.36 (-0.83%)
LRCX : 755.87 (-1.33%)
Why Summit Therapeutics Skyrocketed 123% This Week

Better-than-expected trial data means Summit's bispecific antibody could replace the blockbuster Keytruda as a standard of care for certain lung cancers.

SMMT : 24.56 (-6.33%)
Stocks Climb on Chip Stock Strength and Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.22%. Stocks today are moderately...

$SPX : 5,618.26 (-0.29%)
SPY : 561.40 (-0.30%)
$DOWI : 41,503.10 (-0.25%)
DIA : 416.19 (-0.26%)
$IUXX : 19,344.49 (-0.45%)
QQQ : 471.44 (-0.43%)
ZNZ24 : 114-265 (-0.22%)
MU : 87.35 (-1.56%)
ON : 70.64 (-1.09%)
KLAC : 731.04 (-1.16%)
MCHP : 76.36 (-0.83%)
LRCX : 755.87 (-1.33%)
Why Summit Therapeutics Stock Is Soaring Again Today

This high-flying biotech stock is moving even higher -- and for good reason.

SMMT : 24.56 (-6.33%)
MRK Stock Dips After SMMT's Cancer Drug Outshines Keytruda in Study

Merck’s MRK stock declined 2% on Monday after Summit Therapeutics’ SMMT investigational bispecific antibody, ivonescimab, outperformed Merck’s blockbuster PD-L1 inhibitor Keytruda in a first-line...

RHHBY : 39.6100 (+0.71%)
MRK : 118.64 (+0.30%)
LLY : 904.97 (-0.13%)
SMMT : 24.56 (-6.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 28.88
2nd Resistance Point 27.77
1st Resistance Point 26.17
Last Price 24.56
1st Support Level 23.46
2nd Support Level 22.35
3rd Support Level 20.75

See More

52-Week High 33.89
Last Price 24.56
Fibonacci 61.8% 21.57
Fibonacci 50% 17.76
Fibonacci 38.2% 13.96
52-Week Low 1.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar